Ewan Phillips, Chief Executive Officer of Deltex Medical Group plc (LON:DEMG) tells Proactive Investors they’ve launched a non-invasive High Definition Impedance Cardiography (HD-ICG) module in the UK.
?>
Ewan Phillips, Chief Executive Officer of Deltex Medical Group plc (LON:DEMG) tells Proactive Investors they’ve launched a non-invasive High Definition Impedance Cardiography (HD-ICG) module in the UK.
Turner Pope Investments will be holding an Investor Evening this Monday 13th May 2019. With spaces limited it is important you reserve your spot via the email address at bottom. Venue:The Saloon, The Ned Hotel (www.thened.com), 27
Deltex Medical’s Andy Mears discusses their latest interim results in this exclusive interview with DirectorsTalk
Deltex Medical Group Plc (LON:DEMG) CEO Andy Mears talks to DirectorsTalk about its interim results for the six months period ended 30 June 2018. Andy talks us through the highlights of the results, how he has
Nigel Keen, Chairman of Deltex Medical, commented: “The successful £2,050,000 fund raising in February 2018 has put the Group in a stronger financial position – allowing us to improve our business structure. “We made a number
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, the Group’s Chairman, Nigel Keen, will make the following statement at the Annual General Meeting: Hospitals in the developed world are facing increasing pressure
Deltex Medical Group’s Andy Mears discuss his new role as CEO, plans for the next 12 months and the main opportunities for the business in this exclusive interview with DirectorsTalk
Deltex Medical Group Plc (LON:DEMG) New CEO Andy Mears talks to DirectorsTalk about his new position. Andy talks about his background, how he thinks Deltex is positioned, his plans for the next 12 months and the
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, announced today that Ewan Phillips has resigned as Chief Executive and as a Director of the Company with immediate effect. Mr. Phillips recently approached Deltex’s
The Royal College of Anaesthesia held its flagship event, Anaesthesia 2018 at The British Museum on May 22nd and 23rd. Comprising two days of talks, breakout sessions and debates, it also featured the presentation of the RELIEF
May 28th saw Deltex Medical Group supporting Current Initiatives, Research and the Role of Haemodynamic Monitoring at London’s Montague Hotel. Held under the auspices of the EBPOM organisation (Evidence Based PeriOperative Medicine), the congress saw keynote presentations from
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, today gives notice that its Annual Report and Accounts for the year ended 31 December 2017 has been published on the “Annual & Interim Reports”
Deltex Medical Group’s Ewan Phillips discusses their full year results, what’s been happening operationally, their strategy for the next 12 months and what investors should look forward to in the near future in this exclusive interview with DirectorsTalk
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), today announced that it will be hosting an investor event on 22 May 2018 following the publication of its full year results for
Deltex Medical Group (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its 2017 year end results. Ewan talks us through the highlights, explains whats been happening operationally this year, the strategy for the next 12 months
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), today announced the launch of the TrueVueTM Loops display software on its CardioQ-ODM+ haemodynamic monitoring platform. The TrueVueTM Loops software is being released globally and
Nigel Keen, Chairman of Deltex Medical, commented: “The progress made towards operating cash breakeven and profitability through improved consumable margins and reduced overheads made during 2017 was partially offset by a disappointing second half sales performance.
Deltex Medical will be supporting a forthcoming congress in London on May 28th. Current Initiatives, Research and the Role of Hemodynamic Monitoring is free to attend for clinicians and healthcare providers who are interested in the principles and
It takes a plethora of products and people to provide patients premium protection. Changing payment models, the digitization of healthcare and the need to deliver higher quality care at a lower cost are driving significant change